1. Researchers identified challenges in neovascular age-related macular degeneration (nAMD) management from survey data.
2. They found that patients faced logistical, financial, and psychological hurdles with anti-VEGF therapy.
3. They also noted that communication about treatment expectations and patient education are vital.
4. Strategies to improve nAMD management include appointment reminders and transportation support.
5. Limitations such as data collection during COVID-19 and consideration for patients' health care access and literacy were noted.

Source: Ophthalmology in Therapy